Cargando…

Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis

Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs' Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30....

Descripción completa

Detalles Bibliográficos
Autores principales: Accorinti, Massimo, Spinucci, Giovanni, Pirraglia, Maria Pia, Bruschi, Simone, Pesci, Francesca Romana, Iannetti, Ludovico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066004/
https://www.ncbi.nlm.nih.gov/pubmed/27781126
http://dx.doi.org/10.1155/2016/1458624
_version_ 1782460405867610112
author Accorinti, Massimo
Spinucci, Giovanni
Pirraglia, Maria Pia
Bruschi, Simone
Pesci, Francesca Romana
Iannetti, Ludovico
author_facet Accorinti, Massimo
Spinucci, Giovanni
Pirraglia, Maria Pia
Bruschi, Simone
Pesci, Francesca Romana
Iannetti, Ludovico
author_sort Accorinti, Massimo
collection PubMed
description Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs' Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 months (50 of them had a mean follow-up of 63.5 months) and in those we assessed complications, medical and surgical treatment, and long-term visual prognosis. Results. Average age at uveitis diagnosis was 27.2 years and 18.3% of patients were children. Blurred vision (54.5%) and floaters (40.5%) were the most frequent presenting symptoms. Small to medium-sized keratic precipitates (95.6%), iris atrophy (86.8%), and vitreous opacities (91.2%) were the most common signs; the prevalence of cataract and IOP increase was 63.5% and 20.1%, respectively, and their incidence was 0.1 and 0.06 eye/year. Significant risk factor for visual loss was IOP increase at presentation (p = 0.02). At final examination 98% of the eye had a visual acuity ≥ 0.6, and topical (p < 0.001) and systemic (p < 0.001) corticosteroids therapy were used less frequently than before referral. Conclusions. FHI has a good visual prognosis, despite the significant incidence of cataract and glaucoma. A correct and prompt diagnosis might avoid unnecessary therapies and provide excellent visual outcomes.
format Online
Article
Text
id pubmed-5066004
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50660042016-10-25 Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis Accorinti, Massimo Spinucci, Giovanni Pirraglia, Maria Pia Bruschi, Simone Pesci, Francesca Romana Iannetti, Ludovico J Ophthalmol Research Article Purpose. To study epidemiology, clinical findings and visual prognosis of patients with Fuchs' Heterochromic Iridocyclitis (FHI). Methods. A retrospective analysis was performed on 158 patients with FHI. Thirty-five patients were observed only once; the remaining 123 had a mean follow-up of 30.7 months (50 of them had a mean follow-up of 63.5 months) and in those we assessed complications, medical and surgical treatment, and long-term visual prognosis. Results. Average age at uveitis diagnosis was 27.2 years and 18.3% of patients were children. Blurred vision (54.5%) and floaters (40.5%) were the most frequent presenting symptoms. Small to medium-sized keratic precipitates (95.6%), iris atrophy (86.8%), and vitreous opacities (91.2%) were the most common signs; the prevalence of cataract and IOP increase was 63.5% and 20.1%, respectively, and their incidence was 0.1 and 0.06 eye/year. Significant risk factor for visual loss was IOP increase at presentation (p = 0.02). At final examination 98% of the eye had a visual acuity ≥ 0.6, and topical (p < 0.001) and systemic (p < 0.001) corticosteroids therapy were used less frequently than before referral. Conclusions. FHI has a good visual prognosis, despite the significant incidence of cataract and glaucoma. A correct and prompt diagnosis might avoid unnecessary therapies and provide excellent visual outcomes. Hindawi Publishing Corporation 2016 2016-10-03 /pmc/articles/PMC5066004/ /pubmed/27781126 http://dx.doi.org/10.1155/2016/1458624 Text en Copyright © 2016 Massimo Accorinti et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Accorinti, Massimo
Spinucci, Giovanni
Pirraglia, Maria Pia
Bruschi, Simone
Pesci, Francesca Romana
Iannetti, Ludovico
Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_full Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_fullStr Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_full_unstemmed Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_short Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis
title_sort fuchs' heterochromic iridocyclitis in an italian tertiary referral centre: epidemiology, clinical features, and prognosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066004/
https://www.ncbi.nlm.nih.gov/pubmed/27781126
http://dx.doi.org/10.1155/2016/1458624
work_keys_str_mv AT accorintimassimo fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT spinuccigiovanni fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT pirragliamariapia fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT bruschisimone fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT pescifrancescaromana fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis
AT iannettiludovico fuchsheterochromiciridocyclitisinanitaliantertiaryreferralcentreepidemiologyclinicalfeaturesandprognosis